Work

Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells

Year: 2020

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-020-00901-w

Authors: Feng Qu, Yue Gu, Qizhi Wang, Mingzhe He, Fang Zhou, Jianguo Sun, Guangji Wang, Ying Peng

Institutions: Nanjing Drum Tower Hospital, Nanjing University, China Pharmaceutical University, State Key Laboratory of Natural Medicine

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Nanjing Medical Science and Technique Development Foundation

Awards: G5584361911, G7625073423

OpenAlex ID: W3003286392

FWCI: 3.076

Cites: 41

Cited by: 33

Related to: 10